Sector revisions Virax Biolabs Group Limited

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
0.2066 ^USD	-1.20%		-10.33%	-40.25%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
VIRAX BIOLABS GROUP LIMITED	-	1
LONZA GROUP AG		23
BEONE MEDICINES AG		24
CELLTRION, INC.		23
IQVIA HOLDINGS INC.		20
REVOLUTION MEDICINES, INC.		18
EUROFINS SCIENTIFIC SE		15
ASCENDIS PHARMA A/S		16
IONIS PHARMACEUTICALS, INC.		22
MEDPACE HOLDINGS, INC.		12
QIAGEN N.V.		15
ABIVAX		5
BIO-TECHNE CORPORATION		12
TEMPUS AI, INC.		12
PRAXIS PRECISION MEDICINES, INC.		16
BLUEPRINT MEDICINES CORPORATION	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
PHARMARON BEIJING CO., LTD.		13
HANGZHOU TIGERMED CONSULTING CO., LTD		11
Average		15
Weighted average by Cap.		19